Assembly Biosciences Inc (NASDAQ:ASMB)

Data as of 3:59pm ET
 -0.47 / -5.36%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Assembly Biosciences, Inc. operates as a biopharmaceutical company which develops novel treatments for hepatitis B virus infection and C. difficile-associated diarrhea. It specializes in the development of therapies for infectious diseases like HIV, CDAD and other disorders of the gastrointestinal system including of late-stage and pre-clinical prescription drugs and biologics. The company was founded on October 7, 2005 and is headquartered in New York, NY.

Contact Information

Assembly Biosciences, Inc.
99 Hudson Street
New York New York 10013
P:(646) 706-5208
Investor Relations:



Mutual fund holders6.64%
Other institutional22.84%
Individual stakeholders15.79%

Top Executives

Russell H. EllisonChairman, CEO & Co-Chief Medical Officer
Derek A. SmallPresident, COO, Director & Budget Chief
David J. BarrettChief Financial Officer
Lee D. ArnoldChief Scientific Officer
Uri A. LopatinCo-Chief Medical Officer, Vice President-R&D

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.